NASDAQ : IMPL

Impel Pharmaceuticals Inc.

$0.04 USD

-$0.01 (-27.27%)

Volume
720.03K
Average Volume
1.05M
Market Capitalization
$956K
P/E Ratio
-0.01
Dividend Yield
0.00%
Price Target
Year High
$4.20
Year Low
$0.02
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$3.60
Company Overview

NASDAQ

Leonard S. Paolillo

Biotechnology

Healthcare

IMPL

160

US

USD

https://impelpharma.com

206 568 1466

45258K109

0001445499

Liquidity Metrics

-1.16

3.60

3.22

2.74

0.00

Sales & Valuation

$12.65M

0.08

-0.02

-0.01

-4.05

Profitability

-$5.52

-$129.44M

-1023.08%

-840.28%

-3099.99%

-146.18%

P/E Metrics

-0.01

0.00

0.00

Analyst Price Target & Rating

N/A

0/5

3 Analysts

%

Poll Results

About Impel Pharmaceuticals Inc. (NASDAQ:IMPL) Stock

Impel Pharmaceuticals Inc. operates as a commercial-stage biopharmaceutical firm, concentrating its efforts on creating and commercializing therapies for individuals in the United States who are affected by central nervous system (CNS) conditions. Leading its product portfolio is Trudhesa, an innovative upper nasal formulation of dihydroergotamine, specifically engineered for the prompt relief of acute migraine attacks. Furthermore, the company's development pipeline encompasses INP105, another upper nasal medication containing olanzapine, currently being advanced for the rapid treatment of agitation and aggressive behaviors associated with autism spectrum disorder. Impel is also progressing with INP107, an intranasal carbidopa/levodopa compound, which has already successfully concluded it ... s Phase IIa clinical trial aimed at managing "OFF" episodes in Parkinson's disease patients. Initially established in 2008, the company was formerly known as Impel NeuroPharma, Inc. before rebranding to Impel Pharmaceuticals Inc. in April 2022. Its corporate headquarters are situated in Seattle, Washington.

Frequently Asked Questions

What is the current Impel Pharmaceuticals Inc. (IMPL) stock price?

Impel Pharmaceuticals Inc.(NASDAQ:IMPL) stock price is $0.04 in the last trading session. During the trading session, IMPL stock reached the peak price of $4.2 while $0.0212 was the lowest point it dropped to. The percentage change in IMPL stock occurred in the recent session was --27.27% while the dollar amount for the price change in IMPL stock was -$0.01.

IMPL's industry and sector of operation?

The NASDAQ listed IMPL is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of IMPL?

Leonard S. Paolillo | Interim President & Chief Executive Officer
John D. Hoekman | Co-Founder and Chief Technology & Development Officer
Sarah Wille | Vice President of Human Resources
|
|

How many employees does IMPL have?

Number of IMPL employees currently stands at 160. IMPL operates from 201 Elliott Avenue West, Seattle, WA 98119, US.

Link for IMPL official website?

Official Website of IMPL is: https://impelpharma.com

How do I contact IMPL?

IMPL could be contacted at phone #206 568 1466 and can also be accessed through its website. IMPL operates from 201 Elliott Avenue West, Seattle, WA 98119, US.

How many shares of IMPL are traded daily?

The average number of IMPL shares traded daily for last 3 months was 1.05M.

What is the market cap of IMPL currently?

The market value of IMPL currently stands at $956K with its latest stock price at $0.04